Department of Plastic and Esthetic Surgery, St Anne's University Hospital, Masaryk University, Brno, Czech Republic.
College of Medicine, Chang Gung Universifwardty, Taoyuan.
Int J Surg. 2024 Apr 1;110(4):1913-1918. doi: 10.1097/JS9.0000000000001106.
Contraction-type lymphatic vessels (LV) are considered suboptimal for lymphaticovenous anastomosis (LVA). However, despite these pathological changes, their functionality and link to outcomes have not been fully elucidated. The aim of this study was to determine the impact on outcomes when contraction-type LVs were used for LVA compared to the noncontraction-type (normal + ectatic) counterpart for treating lower limb lymphedema.
Eighty-three patients with gynecologic cancer-related unilateral lower-limb lymphedema who underwent LVA as their primary treatment were enrolled in this study. The study group included 20 patients who used only contraction-type LVs. An additional 63 patients (control group) received noncontraction-type LVs only. Patients with a history of LVA, liposuction, or excisional therapy were excluded. Patient characteristics, intraoperative findings, functional parameters, and pre-LVA and post-LVA volume changes were recorded and matched using propensity scores. The primary endpoint was the volume change at 6/12 months after LVA.
After matching, 20 patients were included in each group. All parameters were matched, except that the study group still had a significantly inferior indocyanine green (ICG)-positive ratio, lymph flow-positive ratio, and washout-positive ratios ( P <0.001, P =0.003, and P <0.001, respectively) when compared to the control group after matching. However, at 1-year follow-up, the postoperative percentage volume reduction was comparable between the groups ( P= 0.619).
The use of contraction-type LVs for LVA is encouraged when no other LVs are available.
收缩型淋巴管(LV)被认为不适合淋巴管静脉吻合术(LVA)。然而,尽管存在这些病理改变,其功能及其与结局的关系尚未完全阐明。本研究旨在确定在治疗下肢淋巴水肿时,与非收缩型(正常+扩张型)相比,使用收缩型 LV 进行 LVA 对结局的影响。
本研究纳入了 83 例妇科癌症相关单侧下肢淋巴水肿患者,这些患者均接受 LVA 作为主要治疗方法。研究组包括 20 例仅使用收缩型 LV 的患者。另外 63 例患者(对照组)仅接受非收缩型 LV。排除有 LVA、脂肪抽吸或切除术治疗史的患者。记录患者特征、术中发现、功能参数以及 LVA 前和 LVA 后的体积变化,并使用倾向评分进行匹配。主要终点是 LVA 后 6/12 个月的体积变化。
匹配后,每组各纳入 20 例患者。所有参数均匹配,但研究组在匹配后仍具有明显较低的吲哚菁绿(ICG)阳性率、淋巴流量阳性率和洗脱阳性率(P <0.001、P =0.003 和 P <0.001)。然而,在 1 年随访时,两组间术后体积减少百分比无差异(P=0.619)。
在没有其他 LV 可供使用的情况下,鼓励使用收缩型 LV 进行 LVA。